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Background: In our previous study that characterized different human CD4+ lymphocyte preparations, it was
found that both commercially available cryopreserved peripheral blood mononuclear cells (PBMC) and a
commercially available lyophilized PBMC (Cyto-Trol™) preparation fulfilled a set of criteria for serving as biological
calibrators for quantitative flow cytometry. However, the biomarker CD4 protein expression level measured for T
helper cells from Cyto-Trol was about 16% lower than those for cryopreserved PBMC and fresh whole blood using
flow cytometry and mass cytometry. A primary reason was hypothesized to be due to steric interference in anti- CD4
antibody binding to the smaller sized lyophilized control cells.
Method: Targeted multiple reaction monitoring (MRM) mass spectrometry (MS) is used to quantify the copy number
of CD4 receptor protein per CD4+ lymphocyte. Scanning electron microscopy (SEM) is utilized to assist searching the
underlying reasons for the observed difference in CD4 receptor copy number per cell determined by MRM MS and
CD4 expression measured previously by flow cytometry.
Results: The copy number of CD4 receptor proteins on the surface of the CD4+ lymphocyte in cryopreserved PBMCs
and in lyophilized control cells is determined to be (1.45 ± 0.09) × 105 and (0.85 ± 0.11) × 105, respectively, averaged
over four signature peptides using MRM MS. In comparison with cryopreserved PBMCs, there are more variations in
the CD4 copy number in lyophilized control cells determined based on each signature peptide. SEM images of
CD4+ lymphocytes from lyophilized control cells are very different when compared to the CD4+ T cells from
whole blood and cryopreserved PBMC.
Conclusion: Because of the lyophilization process applied to Cyto-Trol control cells, a lower CD4 density value,
defined as the copy number of CD4 receptors per CD4+ lymphocyte, averaged over three different production
lots is most likely explained by the loss of the CD4 receptors on damaged and/or broken microvilli where CD4 receptors
reside. Steric hindrance of antibody binding and the association of CD4 receptors with other biomolecules likely
contribute significantly to the nearly 50% lower CD4 receptor density value for cryopreserved PBMC determined
from flow cytometry compared to the value obtained from MRM MS.
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Cluster of differentiation 4 (CD4) is a glycoprotein
expressed on the surface of many different types of im-
mune cells, e.g., T helper cells and monocytes. As a cor-
eceptor, CD4 assists the T cell receptor to initiate T cell
activation and counter attack foreign peptides processed
by antigen presenting cells. In human T lymphocytes,
the CD4 receptor protein encoded by the CD4 gene con-
sists of four distinct extracellular domains (D1 to D4), a
transmembrane domain and a short intracellular tail [1].
Defining T helper cells in immunophenotyping is carried
out by using anti-human CD4 monoclonal antibodies
against part of the four extracellular domains of the re-
ceptor. Numerous reports in the literature indicate that
the CD4 expression level on normal human T helper
cells is fairly consistent [2-5]. Therefore the CD4 recep-
tor protein can serve as a biological calibrator for quan-
tification of the surface and intracellular proteins of
human immune cells using flow cytometry. Biological cali-
brators are essential for the transformation of a linear
fluorescence intensity scale obtained with fluorescent cali-
bration microspheres to an antibody bound per cell (ABC)
scale [6,7].
In our previous study that characterized different hu-
man CD4+ lymphocyte preparations [8], it was found
that both cryopreserved peripheral blood mononuclear
cells (PBMC) and lyophilized control cells (Cyto-Trol™)
generally fulfilled a set of criteria for biological calibra-
tors. The criteria include reproducibility and tightness of
detected CD4 expression, close physical and chemical
resemblance of fresh blood samples, and long term sam-
ple stability under widely used and common storage
conditions. The 16% lower CD4 expression level mea-
sured for the lyophilized control cells compared to cryo-
preserved PBMC and fresh whole blood using both
quantitative flow cytometry and mass cytometry, was
previously hypothesized to be due to steric interference as-
sociated with anti- CD4 antibody binding to the smaller
size lyophilized control cells. That is, the average diameter
of the CD4+ lymophocytes is 6.3 ± 0.4 μm for the lyophi-
lized control cells (Cyto-Trol™) and 7.5 ± 0.4 μm for cryo-
preserved PBMCs, respectively. In the present study, both
targeted mass spectrometry by liquid chromatography
(LC) MRM and scanning electron microscopy (SEM) are
used to determine the underlying reasons for the observed
difference in CD4 expression.
Results
Quantification of endogenous CD4 receptors by MRM MS
A new batch of the isotope labeled internal standard CD4
protein for targeted mass spectrometry-based quantifi-
cation was commercially obtained from Origene. This
internal standard CD4 has the full-length endogenous
human CD4 sequence given in the Additional file 1, arecombinant peptide on each end of the endogenous
CD4 protein, and is isotope-labeled with 15N and 13C
on each lysine and arginine residue. A detailed charac-
terization of the MS standard protein was performed
using our previous published method [9]. The concentra-
tion of the stable isotope labeled standard CD4, Niso, was
calculated according to Eq. 1 given below,
Niso ¼ IisoIr  Nr ; where Ir ¼ In−iso−Iiso  0:31 ð1Þ
Iiso and Ir refer to the intensity of the isotope labeled
peptide peak and intensity of a recombinant CD4 protein
(rCD4) (obtained from NIH AIDS Research & Reference
Reagent Program with a known concentration obtained
from amino acid analysis), respectively. In-iso corresponds
to the intensity of the total non-isotope labeled peptide
peak detected and the constant, 0.31 is the ratio of the
non-labeled to the labeled peptide obtained from the in-
ternal standard CD4. Nr is the mol/L concentration of
rCD4 derived from the amino acid analysis. A final concen-
tration of 0.16 pmol/μL and isotope incorporation of 76.2%
was applied for the present endogenous CD4 quantifica-
tion. The endogenous CD4 protein concentration, Nend
was derived in the same fashion from the ratio of the non-
labeled and labeled MRM transition peak intensities multi-
plied by the known amount of standard spiked into the
sample on the basis of Eq. 2,
Nend ¼ IendIiso  Niso ; where Iend ¼ In−iso−Iiso  0:31
ð2Þ
Iend stands for the intensity of the endogenous CD4
peptide peak.
Target peptide selection for MS quantification was
based on several factors, i.e., ion stability, favorable tran-
sition intensities, and minimum matrix effects. These
factors were individually tested empirically. To avoid the
bias of any single peptide, the CD4 MRM quantification
in any given sample was based on the average value of a
total of 4 signature peptides (P1: ILGNQGSFLTK; P2:
SLWDQGNFPLIIK; P3: ASSIVYK; P4: ATQLQK, de-
fined in Additional file 1). Each peptide was monitored
by 3 pairs of the precursor peptide ion and specific frag-
ment ion (a so called “transition”) [9]. The mean value
of 4 peptides (P1 to P4) was taken as the CD4 density in
each measured sample. Considering the sample to sam-
ple variation due to cell preparation, sample processing
and analysis, we performed multiple biological sample
replications for quantitative analysis of the CD4+ T
cells from each cell source (5 replicates for lyophilized
Cyto-Trol cells and 3 replicates for cryopreserved PBMC).
Because no outlier was found by Grubbs test, the mean
value of these sample replicates was taken as the CD4
Table 1 CD4 density per CD4+ lymphocyte and associated one standard deviation of the mean obtained for Cyto-Trol
from three different production lots and for cryopreserved PBMC from five different production lots
Cyto-Trol PBMC
Replicate 1 2 3 4 5 Mean Density (×105) 1 2 3 Mean Density (×105)
Cell # (×106) 5.25 6.00 6.00 6.00 6.00 - 4.39 4.26 4.32 -
Density averaged over P1 to P4 (×105) 0.85 0.89 0.97 0.67 0.86 0.85(0.11) 1.48 1.52 1.34 1.45(0.09)
For each sample replicate, the CD4+ cell number was provided and the CD4 density value was averaged over 4 peptides, P1 to P4 (See Additional file 1).
Figure 1 CD4 density and associated one standard deviation of
the mean obtained on the basis of different peptides, P1 to P4 by
MRM MS for CD4+ T cells from Cyto-Trol and cryopreserved PBMC.
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ous CD4 quantification are summarized in Table 1.
The copy number of CD4 receptor proteins on the sur-
face of the CD4+ lymphocyte in cryopreserved PBMC
and in lyophilized control cells is (1.45 ± 0.09) × 105 and
(0.85 ± 0.11) × 105, respectively. The CD4 receptor dens-
ity from the lyophilized control cells is significantly lower
than the value from cryopreserved PBMC.
We further analyzed the CD4 copy number obtained
from each peptide in cryopreserved PBMC and in Cyto-
Trol (Figure 1). From 5 Cyto-Trol replicates, the peptide
P1, which is located close to the protein N-terminal of
the CD4 protein and furthest away from cell mem-
brane, gives a lower density value [(0.57 ± 0.12) × 105]
than the other three peptides [P2: (0.95 ± 0.07) × 105; P3:
(1.10 ± 0.33) × 105; P4: (1.16 ± 0.28) × 105]. However, this
low value is not identified as an outlier by Grubbs test on
only four density values determined from four peptides.
By comparison, the density value obtained from the same
P1 peptide from 3 PBMC replicates shows no apparent
difference from the values obtained by the other three
peptides. Interestingly, for Cyto-Trol replicates, the dens-
ity value increases monotonically from P1 to P4, unlike
the value for PBMC replicates showing no specific trend.
Scanning electron microscopy measurements
SEM images of the CD4+ T cells purified from cryopre-
served PBMC, normal donor whole blood and lyophilized
Cyto-Trol cells were obtained using sample preparation
procedures described in the ‘Materials and Methods’.
There was no significant difference observed for the same
sample types when two different procedures were ap-
plied at the last stage of the cover glasses coated with
CD4+ lymphocytes, critical point drying with liquid carbon
dioxide or immersing in hexamethyldisilazane (HMDS).
The CD4+ T cell images are described below in terms of
their overall appearance and approximate diameters de-
fined as the average of two orthogonal measurements.
A representative image of the CD4+ lymphocytes from
whole blood is shown in Figure 2(a1) and showed no sig-
nificant differences from cryopreserved PBMC shown in
Figure 2(b1). Fourteen images acquired for CD4+ lym-
phocytes from whole blood and 7 images for cryopre-
served PBMC indicate that the average diameter of the
CD4+ cells is about 4.7 μm for whole blood and 4.6 μmfor cryopreserved PBMC, respectively, and their micro-
villi are densely packed. Figure 2(a2) and (b2) display
magnified central portions of the CD4+ cell surface, pro-
viding a clearer view of the microvilli structure on both
types of cell surface. The microvilli exhibit diameters of
100 nm to 200 nm and lengths of 500 nm to 1000 nm
estimated manually from the sample images. It is ex-
pected that closely spaced microvilli can hinder the
antibody binding or quench the emission of fluorescent
molecules.
An example of a CD4+ lymphocyte image from lyophi-
lized Cyto-Trol cells is shown in Figure 3a and is very
different when compared to the CD4+ cells from whole
blood and PBMCs shown in Figure 2. The lyophilizing
process is evidently responsible for their generally al-
tered and more tangled appearance. Interestingly, the
microvilli can be elongated (~2.5 μm, Figure 3a, top
center), or as shown in Figure 3b, the microvilli can have
similar diameters except near their narrowed tips. The
average diameter of the CD4+ cells from Cyto-Trol is
about 4.8 μm, similar to those for whole blood and
PBMCs (4.6-4.7 μm). The similar sizes of the CD4+ T
cells obtained from three different sample sources are
mostly due to the cell processing procedure applied, e.g.,
dehydration and critical point drying. Of the total of 15
images obtained there were few exceptions to the thin
and entangled appearance of the lyophilized CD4+ T
cells shown in Figure 3. In two cases the entangled micro-
villi were replaced with fewer truncated and sparsely popu-
lated microvilli (e.g., Figure 4a). The remaining exception
Figure 2 Representative electron microscope images of CD4+ T cells purified from fresh normal donor whole blood (a1, a total of 14
images were recorded) and cryopreserved PBMC (b1, 7 images were recorded) along with the respective magnified central portions of
the CD4+ T cell surfaces (a2 for whole blood and b2 for cryopreserved PBMC, respectively), showing approximate diameters and
lengths of some microvilli.
Figure 3 (a) A representative scanning electron microscope
image of CD4+ T cells purified from Cyto-Trol control cells
(a total of 15 images were recorded): Elongated microvilli can
be seen near the perimeter of the cell; (b) A magnified central
portion of the CD4+ cell surface showing approximate diameters
and length of microvilli.
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densely populated microvilli showed early signs of en-
tanglement (Figure 4b).Quantitative comparison of SEM image characteristics
In order to quantify visually observed differences in
SEM images, we have analyzed 12 images of whole blood
(2 images with size ruler shown in the image files
were omitted from the analyses), 7 images of cryopre-
served PBMC, and 15 images of Cyto-Trol. To avoid cell
segmentation challenges, we extracted automatically
600 × 600 pixels from the center of each image of size
2048 × 1887 since all SEM images are centered on a cell
and a cell radius is about 680 pixels. In order to minimize
the influence of image acquisition noise on surface area
measurements defined in Eq. 3 in the ‘Materials and
Methods’ on ‘Comparison of SEM Image Characteristics’,
we applied a morphological filter with a square kernel of
size 7 pixels to all images. After computing a geodesic
surface area in pixel count per extracted image subarea
(each pixel corresponds to an area of specific μm2/pixel),
we computed sample mean and standard deviation of the
surface area measurements per image label (whole blood,
PBMC and Cyto-Trol). Figure 5 shows the resulting
statistics and their corresponding Gaussian probability
distribution functions (PDFs). The mean surface area for
CD4+ T cells from Cyto-Trol (461207) is smaller than
the surface area of CD4+ T cells from cryopreserved
PBMC (561276) and the area of CD4+ lymphocytes
from whole blood (603836), suggesting fewer and/or
shorter microvillis on the surface of CD4+ T cells from
Figure 4 A few exceptional images other than that shown in
Figure 3a were observed for CD4+ T cells from lyophilized
Cyto-Trol: (a) the entangled microvilli were replaced with
truncated and sparsely populated microvilli in two instances;
(b) densely populated microvilli showed early signs
of entanglement.
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of surface area measured along the horizontal direction
since the correlation between vertical and horizontal
values is 0.98.
Discussion
The CD4 receptor density on T helper cells from cryo-
preserved PBMC is determined to be (1.45 ± 0.09) × 105
copies/cell using the MRM MS method (Table 1). This
result is nearly identical to the value [(1.46 ± 0.03) × 105
copies/cell] reported earlier for the commercial cryo-
preserved human CD4+ T cells with 98.5% purity [9].
Due to the lower number of CD4+ cells enriched fromcryopreserved PBMC in the present study, the standard
deviation of the MRM measurements is larger than that
reported previously though the same fragment peptides
were detected and used for CD4 density value determina-
tions. Nonetheless, the consistent CD4 receptor density
values of two different sample preparations demon-
strate the robustness of the MRM MS method devel-
oped in-house.
It is surprising that the CD4 receptor density value
for CD4+ T cells from PBMC (1.45 × 105 copies/cell) is
about 50% greater than the value determined from flow
cytometry measurements (9.8 × 104 copies/cell) where
unimolar anti-CD4 PE antibodies were used to deter-
mine the ABC value on a human T helper cells [8]. It is
noted that the CD4 density value determined from flow
cytometry measurements is calculated as twice of the
ABC value because each anti-CD4 monoclonal antibody
(clone Leu-3a) binds two CD4 receptors through the
extracellular domain, D1 of CD4 receptor protein on
human T lymphocytes [5]. The SEM images of CD4+
lymphocytes from both cryopreserved PBMC and fresh
whole blood show dense microvilli structures on cell
surfaces. As a result, it is likely that some steric hin-
drance of antibody binding exists and the association of
CD4 receptors with other biomolecules [10-12], i.e.,
CCR5, CXCR4 and lipid rafts, may further prevent the
anti-CD4 antibody binding.
Compared to the CD4 receptor density on CD4+ T
cells from cryopreserved PBMC, the density value ob-
tained for lyophilized Cyto-Trol cells is lower (0.57 × 105
copies/cell from P1, 0.95 × 105 copies/cell from P2,
1.10 × 105 copies/cell from P3, 1.16 × 105 copies/cell from
P4). Because peptides P1 and P2 reside in the CD4
extracellular domain D1 (See Additional file 1) where
anti-CD4 antibodies (clone Leu-3a) are bound in flow
cytometry measurements, it is logical to compare the
CD4 density values obtained from P1 and P2 to the value
estimated from flow cytometry. The values from P1 and
P2 are reasonably consistent with that estimated from
flow cytometry measurements (8.2 × 104 copies/cell) [8].
It is understood that not all CD4 receptors on T cells are
accessible for anti-CD4 antibody binding. The general
agreement of the two results from two different measure-
ment techniques implies that steric hindrance and de-
naturation stresses of the lyophilization process on the
paratope of CD4 receptor proteins [13] are marginal for
preventing the antibody binding to the CD4 receptors.
The SEM images of CD4+ T cells from Cyto-Trol, with
some exceptions, show elongated and entangled micro-
villi structures unlike those observed from cryopreserved
and freshly prepared PBMC. Based on the observation
that the CD4 density values for Cyto-Trol are much
lower than the value for PBMC (1.45 × 105 copies/cell),
and Cyto-Trol was produced from normal donor PBMC
Figure 5 Characterization of horizontal geodesic surface area in pixel count of the three types of cells by Gaussian probability
distribution function (PDF): the sample mean and standard deviation values per cell type are plotted in the main graph; the relative
positions of the three PDFs are displayed in the inset.
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that CD4 receptors on microvilli might be damaged
during the lyophilization process (Figure 3a). In the
quantification of multiple peptides using the MRM MS
method, we observed that the quantity of the peptide P1
(ILGNQGSFLTK) that is close to the N terminal of the
CD4 receptor protein was consistently lower than the
other three peptides in the middle of the receptor protein
(Figure 1). This observation does support the hypothesis
that damage of the CD4 receptor proteins may have oc-
curred in the lyophilzation process. The reported possible
glycosylation on the asparagine near the peptide P4
(ATQLQKN) may generate peptide missed cleavage by
trypsin, resulting in an underestimation of P4 level [14].
This will only increase the difference between P1 and
P4 and support the same conclusion. On the basis of
Spellman et al’s report [14] and our previous quantifica-
tion result [9], the potential glycosylation effect is negli-
gible. The lower CD4 density value from Cyto-Trol cells
measured by both flow cytometry and MRM MS methods
is most likely explained by the damage of the CD4 recep-
tor proteins or broken microvilli (Figures 3a and 4a).
Based on the quantitative surface area measurements
from SEM images (Figure 5), we evaluated a hypothesis
that the surface area measurements of Cyto-Trol and
PBMC came from the same probability distribution
(PDF) as the measurements of whole blood. We modeled
the surface area measurements per cell class with normal
PDF that is uniquely described by its mean and variance
(inset of Figure 5). One can then evaluate hypothesesusing a two-tailed t-test of mean, a chi-squared test of
variance or Kolmogorov-Smirnov test of PDF shape. For
example, for the two-tailed t-test with a significance level
equal to 0.05, we cannot reject the null hypothesis
that the sample mean of PBMC is equal to the mean
of whole blood (p-value is 0.0928 > 0.05). In contrast,
we can reject the null hypothesis that the sample mean of
Cyto-Trol is equal to the mean of whole blood (p-value
is 0.0002 < 0.05). Intuitively, if data points from a class
(Cyto-Trol or PBMC) are coming statistically from the
whole blood then the PDFs of Cyto-Trol and PBMC
would have very close values of sample means and vari-
ances, and hence a significant overlap with the whole
blood PDF (ideally the PDFs have the overlap equal to
one). Thus, the fact that the overlap of the Cyto-Trol
PDF with the whole blood PDF (0.3347) is smaller than
the overlap of the PBMC PDF with the whole blood PDF
(0.8621) implies that PBMC data points are more likely
coming from the whole blood PDF than the Cyto-Trol
data points. Although the number of images per label
is relative low, one could imply that the Cyto-Trol pro-
duction protocol causes the cells to change their surface
roughness 2.6 times more likely than the PBMC protocol
in comparison to the whole blood label. These types of
quantitative image analyses could lead to establishing
better understanding for morphological deviation of
any cell production protocol applied to whole blood
and assisting the production of cell reference materials
with known biomarker expression levels for quantitative
immunophenotyping.
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In this study, the MRM MS and SEM measurements are
used to assess two human blood cell preparations in
search of optimal cell reference materials for quantitative
flow cytometry that are more stable and easier to maintain
than fresh whole blood. Because of the lyophilization
process, the CD4 density value on CD4+ lymphocytes
from Cyto-Trol cells is lower than the value from cryopre-
served PBMC, most likely explained by the truncation of
the CD4 receptor proteins and damaged and/or broken
microvilli where CD4 receptors reside. On the other hand,
steric hindrance of antibody binding and the association
of CD4 receptors with other biomolecules likely contrib-
ute significantly to the close to 50% lower CD4 receptor
density value for cryopreserved PBMC determined from
flow cytometry than the value obtained from MRM MS.
The consistent CD4 expression on T cells in normal
donor PBMC, serving as the biological control enhances
the reliability of clinical diagnostics and immunother-
apies. This CD4 receptor protein also plays a crucial role
in the progression of HIV-1 viral infection in that the
gp120 viral protein binds to the CD4 receptor on T cells,
leading to the viral entry and cell disintegration [15].
Though numerous efforts have been put in the develop-
ment of vaccines against the infection, there is limited
success largely because of the complexity of the viral in-
fection process and limited robust measurement tech-
niques supporting the understanding of the underlying
mechanisms of trial vaccines. The three powerful tech-
niques used in this study, flow cytometry, MRM MS
and scanning electron microscopy, allowed us to better
understand the changes caused by the lyophilization
process on CD4+ lymphocytes. These techniques would
enable the measurements of CD4 receptor density and
the number of anti-CD4 monoclonal antibodies, e.g.,
Ibalizumab [16] and Bispecific Ibalizumab [17], bound to
cells bearing CD4 receptors. These measurements would
greatly help to shed light on the underlying mechanisms
of two trial vaccines for the treatment and prevention of
HIV-1. Furthermore, down modulated CD4 cell surface
expression and subcellular localization [18], and deple-
tion of the surface CD4 protein [19] have been reported
in the literature in some cases of HIV infection. It would
certainly be more challenging to apply these techniques




Anonymous heparinized normal donor samples were ob-
tained from NIH’s Department of Transfusion Medicine
and was exempted for research use by its institutional
review boards (IRB). Cyto-Trol kits including Cyto-Trol™
control cells and reconstitution buffer from three differentproduction lots were obtained from Beckman Coulter
(Fullerton, CA). Cryopreserved PBMC (Catalog Number:
CTL-UP1, five different production lots) and anti-
aggregate wash supplement 20× (Catalog Number: CTL-
AA-001) were purchased from Cellular Technology Ltd.
(Shaker Heights, OH). Anti-CD4 FITC monoclonal
antibody and anti-CD3 APC were purchased from BD
Biosciences (San Jose, CA). Anti-CD14 Pacific Blue
(PB) monoclonal antibody and Dynabeads® Untouched™
Human CD4 T Cells Kit were purchased from Invitrogen
(Carlsbad, CA). An isotope labeled CD4 mass spectrometry
standard protein was obtained from OriGene Technologies
(Rockville, MD). Isotope labels (13C and 15 N) in the CD4
standard protein were introduced on arginine and lysine
residues. All chemicals and reagents, unless indicated spe-
cifically, were from Sigma-Aldrich Inc.
Preparation of human CD4+ T cells
The cryopreserved PBMC were thawed following a
protocol provided by Cellular Technology that was de-
scribed in detail in the previous study [8]. The lyophi-
lized control cells in a vial were reconstituted in 1 mL of
reconstitution buffer provided in the Cyto-Trol kit. Both
thawed cryopreserved PBMCs and reconstituted lyophi-
lized control cells were washed once and resuspended
in phosphate-buffered saline (PBS) with 1% fetal bovine
serum (FBS). The cell number was counted by using a
hemocytometer after trypan blue staining.
For the MRM measurements, human CD4+ lympho-
cytes from cryopreserved PBMC and lyophilized control
cells were obtained through a negative selection by using
Dynabeads Untouched Human CD4 T Cells with a
modified enrichment protocol. Briefly, 100 μL heat inac-
tivated FBS was added to 4 × 107 PBMCs in 300 μL isola-
tion buffer [PBS supplemented with 0.1% bovine serum
albumin (BSA) and 2 mM EDTA] in a 2 mL centrifuge
tube and was followed by addition of 100 μL antibody
mix. The antibody mix contains mouse IgG antibodies
towards human CD8, CD14, CD16 (specific for CD16a
and CD16b), CD19, CD36, CD56, CDw123 and CD235a.
The mixture in the tube was placed on an orbital shaker
at 30-60 rpm and incubated for 1 hr at 4°C. After the
mixture was washed twice with 1.2 mL isolation buffer,
the cells were resuspended in 300 μL isolation buffer;
500 μL pre-washed Dynabeads were added followed by
incubation for 30 min on a gentle rotating shaker at
room temperature. The mixture was transferred to a
15 mL centrifuge tube with isolation buffer to reach a
final volume of 3 mL. The bead-bound cells were mixed
thoroughly with a pipette that had a narrow tip opening
to avoid foaming. The tube was placed in a 15 mL/50 mL
tube magnet from Qiagen (Valencia, CA) for 2 min and
the supernatant containing the human CD4+ T cells
were transferred to a new 15 mL tube. An additional
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Dynabeads and the bead-bound cells were resuspended
thoroughly with a pipette as described above. This tube
was placed in the magnet for 2 min, and the supernatant
was collected and combined with the previous super-
natant. Lastly, the combined supernatant tube was placed
in the magnet for 2 min to further remove residual magnet
beads. The supernatant was centrifuged at 400 g for
10 min, and the supernatant was discarded. The purified
cells were washed once and resuspended in PBS with 1%
FBS. The total number of the purified cells including
CD4- and CD4+ T cells and residual monocytes was
counted at least three times using the hemocytometer
and recorded.
The purified cells (1 × 105) were stained with 25 μL
anti-CD4 FITC, 5 μL CD3 APC and 6 μL anti-CD14 PB
to account for contribution of CD4 receptor proteins
from the residual monocytes in the purified cells. After
one wash with 1% FBS in PBS, the stained cells were re-
suspended in 0.5 mL PBS with 1% FBS and run on a
FACSAria II flow sorter. For the purified cells from cryo-
preserved PBMC, the percentage of CD4+ cells was
93.9 ± 0.9% from three replicates and the percentage
of the monocytes with low CD4 expression in the CD4+
cells was 1.2 ± 0.1% from three replicates. For the MRM
measurements, the number of CD4+ cells was taken
as the product of the total cell number obtained by
hemocytometer and 0.939. On the basis of the fluores-
cence intensity that is assumed to be proportional to the
CD4 receptor density and number of the residual mono-
cytes with low CD4 expression and normal CD4+ T cells,
a correction factor (1.01) was applied to the CD4 recep-
tor density value derived from the MS measurements for
all CD4+ cells to obtain the CD4 density value for just
CD4+ T cells.
For the purified cells from the lyophilized control
cells (Cyto-Trol™), the percentage of CD4+ cells was
68.5 ± 0.5% from three replicates and the percentage
of the residual monocytes with low CD4 expression in
the CD4+ cells was 7.9 ± 0.4% from three replicates. For
the MS measurements, the number of CD4+ cells was
taken as the product of the total cell number obtained by
hemocytometer and 0.685. Based on the fluorescence in-
tensity and number of the monocytes with low CD4 ex-
pression and normal CD4+ T cells, a correction factor
(1.06) was applied to the CD4 receptor density derived
from the MS measurements for all CD4+ cells to obtain
the CD4 density value for only the CD4+ T cells.
Sample processing for MRM measurements
The preparation procedure of human CD4+ T cells for
MRM measurements is described in our previous report
[9] with minor revision. Briefly, the isotope labeled full-
length internal standard CD4 was mixed with a knownnumber of human T cells in 150 μL of 25 mmol/L am-
monium bicarbonate buffer (Abb), pH 7.9, with 2% SDS.
The cell and protein mixture was lysed by brief sonication
at 20 W using three 10 s continuous cycles (Sonicator
3000 from Misonix, Farmingdale, NY). The cysteine re-
duction and alkylation of the proteins were carried out by
the treatment with 20 mmol/L DTT at room temperature
for 60 min followed by incubation with 50 mmol/L iodoa-
cetamide for 60 min. The cell lysate was centrifuged at
175,000 g for 30 min to remove insoluble fragments.
Chloroform/methanol treatment [9,20] was then per-
formed to precipitate proteins from supernatant and to
remove salts and lipids. The precipitated protein mixture
was reconstituted in 100 μL of 25 mmol/L Abb contain-
ing 0.1% RapiGest followed by protease digestion using
trypsin [Sequence Grade Modified, Promega, 1:50 (w:w)
trypsin: protein] overnight at 37°C. After enzymatic di-
gestion, the sample was treated with 0.5% trifluoroacetic
acid for 30 min at 37°C and centrifuged at 175,000 g for
30 min. The supernatant, which contains soluble pep-
tides, was transferred to a new microcentrifuge tube and
dried by vacuum centrifugation (Eppendorf AG, Hamburg,
Germany) for subsequent mass spectrometry analysis.
Nano-LC-MRM analysis
The digested peptides were reconstituted in Milli-Q
H2O with 3% acetonitrile (ACN) containing 0.1% formic
acid followed by nano-LC-MRM analysis. Peptide separ-
ation and mass spectrometry analysis were performed
on a hybrid triple quadrupole/linear ion trap mass spec-
trometer (4000 QTRAP, ABI/MDS-SCIEX) coupled to
an Eksigent nanoLC-2D system (Dublin, CA). Peptides
were separated and eluted at a flow rate of 300 nL/min
over a 30 min gradient of acetonitrile from 15% to 35%
in H2O containing 0.1% formic acid using an Eksigent
cHiPLC- nanoflex system equipped with a nano cHiPLC
column, 15 cm × 75 μm, packed with ReproSil-Pur C18-
AQ, 3 μm (Dr. Maisch, Germany). The eluted peptides
were directed into the mass spectrometer with a nanos-
pray source. The subsequent MRM detection of CD4
signature peptides was performed in the positive ion
mode with the following key parameters: an ion spray
voltage of 2,300 V, curtain gas of 18 psi, source gas of
30 psi, interface heating temperature of 170°C, decluster-
ing potential of 76 V for +2 precursor ions and 65 V
for +3 precursor ions, collision cell exit potential of 16 V
for +2 precursor ions and 13 V for +3 precursor ions,
and dwell time of 40 ms for each transition pair. The
collision energy of each target transition was optimized
empirically as reported in the previous study [9]. To de-
velop the MRM method, peptide selection was based on
several criteria including peptide mass is preferably be-
tween 700-2500 Da, and cysteine/methionine containing
peptides are avoided for quantification purpose. Since
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protein can be different in different mass spectrometers,
we selected and optimized the target CD4 peptides and
working MS parameters based on favorable transition
peak intensities, stable retention times, and minimum
biological matrix effects. Considering the complexity of
cell lysate, the proportional intensity ratios of the mul-
tiple target transitions of the selected peptides from
standard CD4 and the counterpart in cell lysate con-
firmed minimal interference from the biological matrix.
Each selected peptide was confirmed as a unique CD4
peptide by sequence blast against human non-redundant
genome database (NCBI).
The mass spectrometer was operated using Analyst
1.5.1 (AB SCIEN). Calibration curves showed linearity
and low scatter over the range of 0.1 – 5 pmol/μL tested
for the internal standard. The endogenous CD4 protein
concentration was derived from the ratio of the non-
labeled and labeled MRM peak intensities multiplied by
the known amount of the internal standard. The iden-
tities of the selected peptides were confirmed based on
the two parameters of the internal standard run under
the same conditions, the retention time of the given pep-
tide and the proportional ratio among the MRM transi-
tions. Each pair of transition from a given peptide was
treated as an independent measure for the peptide,
resulting in a concentration value expressed as copy
number of the quantified peptide per cell. Analysis of
each selected signature peptide was based on the mean
value of multiple transitions from the peptide. Four sig-
nature peptides were employed to evaluate the endogen-
ous CD4 concentration. Each sample was measured in
triplicate and a total of at least three cell lysate replicates
were prepared and measured independently.
Scanning Electron Microscopy (SEM) measurements
For obtaining SEM images of CD4+ T cells from hepa-
rinized normal donor whole blood, cryopreserved PBMC
and lyophilized control cells, CD4+ lymphocytes were
sorted using a FACSAria II sorter. These PBMCs were
labeled with anti-CD3 APC, anti-CD4 FITC and anti-
CD14 PB to collect only CD3 +CD4 +CD14- lymphocytes
and to minimize the monocyte contribution. The sorted
CD4+ Tcells were then centrifuged at 350 g for 10 minutes
and fixed overnight in 2% glutaraldehyde in PBS, pH 7.4.
The CD4+ cells were further washed twice with PBS and
resuspended in a small volume of PBS. A modified proced-
ure from Singer [10] and Majstoravich [21] was used for
coating CD4+ lymphocytes on glass slides. Briefly, a 20 μL
of cell suspension was placed on a cover glass coated with
0.1% poly-L-lysine. After 30 minutes, cells on the cover
glass were treated with the same glutaraldehyde fixative for
30 minutes. The cells were washed once with PBS and
postfixed in 1% osmium tetroxide in PBS for 1 hour. Afterdehydration in ethanol, once with 70% for 10 minutes,
once with 95% for 10 minutes and three times with 100%
for 10 minutes, CD4+ cells on cover glass were treated
by either critical point drying with liquid carbon dioxide
or immersed in hexamethyldisilazane (HMDS; Aldrich,
Atlanta, GA) for 5 min. The cover glasses treated with
HMDS were placed in a vacuum desiccator at room tem-
perature to be air-dried overnight.
The samples were imaged in an FEI Quanta 200 field
emission environmental scanning electron microscope
(FE-ESEM). All images were collected at 10 keV with a
spot size of 2.5 μm. The specimen chamber was at full
vacuum (<5 × 10−3 Pa), and the Everhart-Thornley sec-
ondary electron detector was used to form the images.
Although some specimen charging did occur, the addition
of 10 nm of gold to the surface (via plasma magnetron
sputter coating) was sufficient to eliminate most charging
effects. Beam damage was reduced by integrating the signal
over eight short scans, rather than a single, longer scan.
The image scale was calibrated according to the Geller
Magnification Reference Standard. All images were saved
in the 256 gray scale tagged image format (.tif).
Comparison of SEM image characteristics
Based on the visual observations of key biological de-
scriptors such as the density and shape of microvillis, we
pursued the quantitative SEM image analyses by esti-
mating cell surface roughness as an approximation to
microvilli density/coverage, shape/geometry and length.
Although SEM images do not provide direct 3D surface
measurements, 3D depth maps can be derived by using
photogrammetry or stereo (shape from shading) tech-
niques [22] for their applications to SEM [23]. Unfortu-
nately, these techniques cannot be applied to biological
samples since they require multiple acquisitions while
the sample may be altered or damaged after one image ac-
quisition. Nevertheless, we assume that the SEM image
shades of gray correlate with the thickness of microvillis at
the tangential plane to a cell (e.g., with respect to a frontal
view). We also assume that the cell surface at the root of
microvillis does not change its composition (and hence
SEM intensities) across the tangential plane to a cell.
Under these assumptions, we can evaluate the cell surface
roughness by computing a geodesic surface area in either
horizontal or vertical direction. The area computation can
be implemented by adding intensity increments along ei-












I row; colð Þ−I rowþ 1; colð Þk k
ð3Þ
where A is the area, and I is the intensity of the SEM
image. Row and Col entries are constrained to an image
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nally, the statistics of all surface area measurements over
each category (whole blood, PBMC, and Cyto-Trol) of
images can be compared to determine the differences
between whole blood and the other two cell categories.
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Additional file 1: Sequence of human CD4 receptor protein and
four peptide sequences within the extracellular domains of the CD4
receptor protein detected by MRM MS method.
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